(Q43770761)

English

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant (English)

1 reference

Europe PubMed Central

26 November 2017

Koen van Besien

14

1 reference

Europe PubMed Central

26 November 2017

author name string

Devine SM

1

1 reference

Europe PubMed Central

26 November 2017

Sanborn R

2

1 reference

Europe PubMed Central

26 November 2017

Jessop E

3

1 reference

Europe PubMed Central

26 November 2017

Stock W

4

1 reference

Europe PubMed Central

26 November 2017

Huml M

5

1 reference

Europe PubMed Central

26 November 2017

Peace D

6

1 reference

Europe PubMed Central

26 November 2017

Wickrema A

7

1 reference

Europe PubMed Central

26 November 2017

Yassine M

8

1 reference

Europe PubMed Central

26 November 2017

Amin K

9

1 reference

Europe PubMed Central

26 November 2017

Thomason D

10

1 reference

Europe PubMed Central

26 November 2017

Chen YH

11

1 reference

Europe PubMed Central

26 November 2017

Devine H

12

1 reference

Europe PubMed Central

26 November 2017

Maningo M

13

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

26 November 2017

28

1 reference

Europe PubMed Central

26 November 2017

6

1 reference

Europe PubMed Central

26 November 2017

557-562

1 reference

Europe PubMed Central

26 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703198

0 references

Leukemia: management of relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

21 January 2018

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703198

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703198

1 reference

Europe PubMed Central

26 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43770761&oldid=2103184710"